US$ 22.25
glp 1 psoriatic arthritis Frontiers Glucagon-like peptide-1 receptor agonists in
Description
Clinical trial context: According to the manufacturer, the STEP 1 trial demonstrated 14.9% average body weight loss over 68 weeks among participants who also followed reduced-calorie diets and increased physical activity

These can include: Nausea Vomiting Diarrhea Constipation Stomach pain or discomfort Often, these side effects are mild and tend to get better as your body adjusts to the medication
2025 doi: 10.1007/s11606-025-09509-3

[DOI] [PubMed] [Google Scholar] 32.Slattery DA, Cryan JF

doi: 10.1007/PL00012499 115 MonjoMRodrguezAMPalouARocaP
